ONE INJECTION IS MOBILITY FOR OVER ONE YEAR
Discover how Spryng™ with OsteoCushion™ Technology is different and can positively impact your veterinary practice and patients' lives.
Discover how Spryng™ with OsteoCushion™ Technology is different and can positively impact your veterinary practice and patients' lives.
Spryng™ with OsteoCushion™ Technology is an intra-articular injection comprised of patented,
gel-like biomaterial for companion animal osteoarthritis.
Our leading product, Spryng™ with OsteoCushion™ Technology, is a veterinary device designed to help reinforce articulating cartilage tissue for the treatment and prevention of osteoarthritis. This system uses an intra-articular injection of cartilage-like particles to enhance the force cushioning function of the synovial fluid, first developed and tested for equine and canine animals.
Since Spryng™ mimics the joint function of the articulating cartilage and synovial fluid by dampening mechanical forces and reducing friction without pharmacologic, chemical or metabolic action, we believe it is considered a medical device by FDA guidelines.
Spryng™ with OsteoCushion™ Technology not only provides immediate treatment for cartilage damage, it also provides long-term joint reinforcement and protection from regular stress and strain, allowing a longer “Running is Life” happy existence for our animals. Made into a strong, hydrated material from natural tissue matrix scaffolding components, collagen, elastin and heparin, Spryng™ particles are injected into the synovial space to uniquely reinforce native cartilage by matching its wet, slippery form and cushioning function. These injected sterilized, hydrogel micro-particles are precisely sized to allow easy injection and correct articular spacing for less pain joint motion.
Osteoarthritis (OA), Degenerative Joint Disease and cartilage injury, detected and treated early with Spryng™ will show the best results. Injected Spryng™ particles rapidly reduce pain with slippery force cushioning support to reinforce cartilage tissue function and prevent further damage. Since Spryng™ particles are too large to seep through synovial membranes, they stay in the articulating space to provide their slippery cushioning effects for a long duration.
These particles are made of natural components tightly cross-linked together to form a strong matrix material that resists enzymatic degradation, inhibits immune cell recognition, and therefore, avoids the need for allergy pretesting. Over five years of case studies have provided positive testimonials from many veterinarians, and no adverse effects have been observed other than some mild, short-term injection site swelling.
CASE STUDY 1: KONA


CASE STUDY 2: SHEP
CASE STUDY 3: BRUCE


EVEN MORE CASE STUDIES
Testimonial
Chris, Hope's pet parent, shares his personal experience with Spryng™. At just 1 years old, Hope developed a limp in her left leg and struggled with discomfort. After a veterinary check-up, Hope was diagnosed with congenital arthritis. The only 2 options provided were a hip replacement or pain medication. However, Chris was then introduced to Spryng™, which, after treatment, allowed Hope to walk again with balance and ease for 9 more years! Hope now walks and runs, leading a normal dog life every day for her and for Chris.
Testimonial
One of Dr. Stern's patients, a year-and-a-half year-old Mastiff was crippled with degenerative shoulder issues. After multiple diagnoses, it was claimed there was nothing to be done to help the Mastiff. However, Dr. Stern tried Spryng™ by injecting it into the Mastiff's shoulder. "The very next day the dog was running around!" For more insight and animal case studies, watch the video.

“I think Spryng™ is an extremely useful product for improving joint function. I’ve used it many times with outstanding results.”
Dr. Michael Sterns
Veterinarian with 35+ years experience